Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Financing Arrangements

30 Sep 2009 15:07

RNS Number : 9643Z
Mavinwood PLC
30 September 2009
 



Financing Arrangements

Mavinwood plc ("Mavinwood" or the "Company") announces that it has reached agreement with Lloyds to amend the facility agreement dated 29 July 2009 that Mavinwood entered into with Lloyds TSB Bank plc (the "Lloyds Facility"). In connection with the amendment of the Lloyds Facility, Mavinwood has entered into subordinated working capital facilities with Geraldton Services, Inc. ("Geraldton") as follows (the "Subordinated Loans"):

a new £3.1 million facility due to be repaid on 1 August 2012 with interest to be compounded annually and paid on the date of repayment of the loan. It is intended that the £3.1 million loan will be used to reduce outstanding bank borrowings; and

in substitution for the £2.5 million short term facility previously made available by Geraldton, a new £2 million facility due to be repaid on 1 August 2012 with interest to be compounded annually and paid on the date of repayment of the loan.

Under the terms of the Lloyds Facility, Mavinwood was required to raise a minimum of £6 million (gross) in cash by 30 September 2009. The Lloyds Facility has been amended and now requires a minimum equity injection by 31 December 2009 of an amount equal to (i) the Subordinated Loans (including rolled-up interest) plus (ii) the previously announced fee of £900,000 payable to Geraldton in connection with their equity underwriting commitment The Geraldton underwriting fee and the Subordinated Loans (including interest) will become payable as and when the above equity investment is made.

Geraldton's underwriting commitment to invest a further sum of up to £4 million on or before 31 January 2010, should it be required, remains in place. Geraldton's underwriting commitment has been varied to reflect the above.

Geraldton is a related party (as defined in the AIM Rules) and the provision of the Subordinated Loans and variation of Geraldton's underwriting commitment constitute related party transactions under the AIM Rules (together the "Transaction"). The Board considers, having consulted with its nominated adviser, Collins Stewart, the terms of the Transaction to be fair and reasonable in so far as the Company's shareholders are concerned. For the purpose of considering the Transaction, Mr Wilson is not regarded as an "independent" director because of his formal links to Lord Ashcroft KCMG, who controls Geraldton. It was therefore agreed that Mr Wilson would not vote, and did not vote, at the Board meeting when the above related party transactions were voted on.

Enquiries to:

Mavinwood plc

Charles Skinner 07966 234075

Collins Stewart

Adrian Hadden 020 7523 8350

Threadneedle Communications

John Coles 020 7653 9848

Collins Stewart Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as nominated adviser to Mavinwood plc and is acting for no-one else in connection with the related party transactions and will not be responsible to anyone other than Mavinwood plc for providing the protections afforded to clients of Collins Stewart Europe Limited nor for providing advice in connection with the related party transactions or any other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFBLFXKKBXBBZ
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.